Danielle Scelfo

Danielle is an accomplished health policy strategist who has led teams across government affairs, market access, and reimbursement functions for over 25 years. Her extensive subject matter expertise guided innovative payment reforms across precision medicine diagnostics during her tenure at Sanofi Aventis, Genomic Health, Adaptive Biotechnologies, and Hologic. A principal voice in diagnostic health policy, Danielle has chaired the Coalition for 21st Century Medicine Reimbursement and Policy Workgroup, the California Healthcare Institute Diagnostic Workgroup, and participated in several CPT working groups for the American Medical Association. A member of leading federal and state diagnostic trade associations, Danielle earned her Master’s in Health Administration at Florida International University and a Bachelor of Science in Marketing from the University of Florida.